Overexpression of MDM2 in leukemic cells in previously treated patients with chronic lymphocytic leukemia.

被引：0
|
作者：
Shinn, CA
Byrd, JC
Neuberg, DS
Flinn, IW
Grever, MR
机构：
[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21205 USA
[2] Walter Reed Army Med Ctr, Hematol Oncol Serv, Washington, DC 20307 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2422
引用
收藏
页码：542A / 542A
页数：1
相关论文
共 50 条
  • [41] Safety and efficacy of Ibrutinib in Indian patients with chronic lymphocytic leukemia.
    Gogia, Ajay
    Sharma, Atul
    Gupta, Ritu
    Rani, Lata
    Mallick, Saumyaranjan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia
    Boogaerts, MA
    Van Hoof, A
    Catovsky, D
    Kovacs, M
    Montillo, M
    Zinzani, PL
    Binet, JL
    Feremans, W
    Marcus, R
    Bosch, F
    Verhoef, G
    Klein, M
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (22) : 4252 - 4258
  • [43] FLUDARABINE PLUS DOXORUBICIN IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
    ROBERTSON, LE
    OBRIEN, S
    KANTARJIAN, H
    KOLLER, C
    BERAN, M
    ANDREEFF, M
    LERNER, S
    KEATING, MJ
    LEUKEMIA, 1995, 9 (06) : 943 - 945
  • [44] FLUDARABINE PLUS DOXORUBICIN IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
    ROBERTSON, LE
    OBRIEN, S
    KANTARJIAN, H
    KOLLER, C
    BERAN, M
    ANDREEFF, M
    LERNER, S
    KEATING, MJ
    BLOOD, 1993, 82 (10) : A140 - A140
  • [45] Epstein-Barr virus in patients with chronic lymphocytic leukemia.
    Tsimberidou, AM
    Keating, MJ
    Bueso-Ramos, C
    Kurzrock, R
    BLOOD, 2005, 106 (11) : 598A - 598A
  • [46] DINACICLIB AND DINACICLIB GLUCURONIDE PHARMACOKINETICS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA.
    Zhao, Y.
    Ling, Y.
    Kolli, S.
    Poi, M.
    Schaaf, L. J.
    Johnson, A. J.
    Byrd, J. C.
    Jones, J. A.
    Phelps, M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S95 - S95
  • [47] ASSOCIATION BETWEEN THE MDM2 SNP309 POLYMORPHISM AND CLINICAL OUTCOME IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH UNMUTATED IGHV GENES
    Bilous, N.
    Abramenko, I.
    Chumak, A.
    Martina, Z.
    Kryachok, I.
    Filonenko, I.
    Gusachenko, J.
    HAEMATOLOGICA, 2013, 98 : 539 - 539
  • [48] Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia
    Kucuk, O
    Kilton, L
    Wade, JL
    Blough, R
    Benson, AB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (04): : 379 - 383
  • [49] Phase 1 Trial of Flavopiridol and Lenalidomide In Patients with Previously Treated Chronic Lymphocytic Leukemia (CLL)
    Blum, Kristie A.
    Jones, Jeffrey A.
    Andritsos, Leslie
    Flynn, Joseph M.
    Deam, Deidre
    Heerema, Nyla A.
    Phelps, Mitchell
    Johnson, Amy J.
    Grever, Michael R.
    Byrd, John C.
    BLOOD, 2010, 116 (21) : 1027 - 1027
  • [50] Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine
    Rai, KR
    Freter, CE
    Mercier, RJ
    Cooper, MR
    Mitchell, BS
    Stadtmauer, EA
    Santábarbara, P
    Wacker, B
    Brettman, L
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (18) : 3891 - 3897
12345